Corey Hayes, Pharm.D., Ph.D., MPH

HayesPositions

Assistant Professor, Department of Psychiatry and Behavioral Sciences, College of Medicine
Assistant Professor (Secondary), Department of Biomedical Informatics, College of Medicine
Assistant Professor (Secondary), Department of Pharmacy Practice, College of Pharmacy
Research Health Scientist, Center for Mental Healthcare and Outcomes Research (CeMHOR), Central Arkansas Veterans Healthcare System

Contact

UAMS e-mail: cjhayes@uams.edu
VA E-mail: corey.hayes@va.gov
Phone: 501-526-8133

Research Expertise

Dr. Hayes is a clinical pharmacist, epidemiologist, and addiction health services researcher. Dr. Hayes uses population-level claims and electronic health record data and advanced quantitative methods to improve prevention and treatment of substance use disorders. His work focuses on improving policies related to opioid prescribing and developing technology-based interventions for improving treatment of patients with opioid use disorder.

Dr. Hayes received his Pharm.D. and MPH. from UAMS in 2013 and practiced for 3 years as a clinical pharmacist at Baptist Health Medical Center in Little Rock, Arkansas. From 2016-2018, Dr. Hayes completed a NIDA funded T32 Post-Doctoral Fellowship in Translational Addiction Research and completed his Ph.D. in Pharmaceutical Evaluation and Policy with an emphasis in pharmacoepidemiology.

Research interests: substance use disorders, pharmacoepidemiology, secondary data analyses, technology-based interventions

Translational Research Institute profile

Recent Publications

  1. Hayes CJ, Payakachat N, Li C. Evaluation of opioid use among patients with back disorders and arthritis. Qual Life Res. 2018 Nov;27(11):3021-3035. doi: 10.1007/s11136-018-1941-1. Epub 2018 Jul 23. PMID: 30039181; PMCID: PMC7193692.
  2. Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use – United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):265-269. doi: 10.15585/mmwr.mm6610a1. PMID: 28301454; PMCID: PMC5657867.
  3. Shah A, Hayes CJ, Martin BC. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies. J Pain. 2017 Nov;18(11):1374-1383. doi: 10.1016/j.jpain.2017.06.010. Epub 2017 Jul 13. PMID: 28711636; PMCID: PMC5660650.
  4. Young SG, Hayes CJ, Aram J, Tait MA. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1117-1124. doi: 10.1002/pds.4838. Epub 2019 Jun 5. PMID: 31168860; PMCID: PMC6679752.
  5. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. J Gen Intern Med. 2019 Aug;34(8):1419-1426. doi: 10.1007/s11606-018-4782-2. Epub 2019 Jan 25. PMID: 30684198; PMCID: PMC6667507.
  6. Bhandari NR, Kathe N, Hayes C, Payakachat N. Reliability and validity of SF-12v2 among adults with self-reported cancer. Res Social Adm Pharm. 2018 Nov;14(11):1080-1084. doi: 10.1016/j.sapharm.2018.01.007. Epub 2018 Jan 31. PMID: 29366669; PMCID: PMC7301412.
  7. Kathe N, Hayes CJ, Bhandari NR, Payakachat N. Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population. Value Health. 2018 Apr;21(4):432-440. doi: 10.1016/j.jval.2017.09.007. Epub 2017 Nov 10. PMID: 29680100.
  8. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. J Opioid Manag. 2017 Mar/Apr;13(2):95-103. doi: 10.5055/jom.2017.0373. PMID: 28829524.
  9. Hayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health- Related Quality of Life among Chronic Opioid Users, Nonchronic Opioid Users, and Nonopioid Users with Chronic Noncancer Pain. Health Serv Res. 2018 Oct;53(5):3329-3349. doi: 10.1111/1475-6773.12836. Epub 2018 Feb 25. PMID: 29479700; PMCID: PMC6153159.
  10. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self- inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction. 2020 Jun;115(6):1098-1112. doi: 10.1111/add.14940. Epub 2020 Jan 15. PMID: 31944486; PMCID: PMC7263736.
  11. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1180-8. doi: 10.1002/pds.3851. Epub 2015 Aug 6. PMID: 26248742; PMCID: PMC5305002.
  12. Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 Jun;47(6):1555-61. doi: 10.1161/STROKEAHA.115.012325. Epub 2016 Apr 21. PMID: 27103018.
  13. Hayes CJ, Bhandari NR, Kathe N, Payakachat N. Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in Adults with Non- Cancer Pain. Healthcare (Basel). 2017 Apr 26;5(2):22. doi: 10.3390/healthcare5020022. PMID: 28445438; PMCID: PMC5492025.
  14. Nowak G, Bakajsova D, Hayes C, Hauer-Jensen M, Compadre CM. γ-Tocotrienol protects against mitochondrial dysfunction and renal cell death. J Pharmacol Exp Ther. 2012 Feb;340(2):330-8. doi: 10.1124/jpet.111.186882. Epub 2011 Oct 31. PMID: 22040679; PMCID: PMC3263958.
  15. Hudson TJ, Fortney JC, Williams JS, Austen MA, Pope SK, Hayes CJ. Effect of rural residence on use of VHA mental health care among OEF/OIF veterans. Psychiatr Serv. 2014 Dec 1;65(12):1420-5. doi: 10.1176/appi.ps.201300041. Epub 2014 Oct 31. PMID: 25081581.
  16. Martin BC, Hayes C, Austen M, Hudson T. Author response to “Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion”. Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):477-8. doi: 10.1002/pds.3972. PMID: 27059545.
  17. Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 Apr;23(4):451-460. doi: 10.1016/j.jval.2019.12.002. Epub 2020 Feb 10. PMID: 32327162.
  18. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on pain intensity: a retrospective cohort study. Pain. 2020 May;161(5):979-988. doi: 10.1097/j.pain.0000000000001784. PMID: 31917775.
  19. Hayes C, Hutchison LC. Development and evaluation of a student-led Medicare Part D Planning Clinic. Consult Pharm. 2013 Apr;28(4):237-42. doi: 10.4140/TCP.n.2013.237. PMID: 23552704.